Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,125 Jan 1 – Oct 9, 2026
- Disclosed funding
- $199.2B 1759 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| KT Develops inhaled therapies for severe respiratory diseases | $103M | Series B | Biotech | United States | Investors | |
| VS Develops a ureteroscopic system for complete kidney stone clearance | $30M | Series A | Healthtech | United States | Investors | |
| R Provides enterprise-grade infrastructure for stablecoin-powered payments | $250M | Series CSeries C+ | Fintech | United States | Investors | |
| MM Major Medical DevicesCompany profile Develops innovative vascular intervention solutions for abdominal aortic aneurysms Develops innovative vascular intervention solutions for abdominal aortic aneurysms | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| B BradoCompany profile Provides Conversational Engagement Platform for patient navigation and engagement Provides Conversational Engagement Platform for patient navigation and engagement | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
| M MEDIPOSTCompany profile MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. | $140M | Undisclosed | Biotech | United States | Investors | |
| CI Provides AI-native, full-stack insurance for startups | $108M | Series A | Fintech | United States | Investors | |
| H Builds highly automated factories producing defense and aerospace systems | Undisclosed | Undisclosed | Industrial tech | United States | Investors | |
| AT AirNexis TherapeuticsCompany profile AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. | $200M | Series A | Biotech | United States | Investors | |
| P ProtegeCompany profile Provides AI data platform unlocking access to trusted real-world data at scale Provides AI data platform unlocking access to trusted real-world data at scale | $30M | Series A | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.